These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 37492224)

  • 141. Cancer stem cell characteristics and their potential as therapeutic targets.
    Lim JR; Mouawad J; Gorton OK; Bubb WA; Kwan AH
    Med Oncol; 2021 May; 38(7):76. PubMed ID: 34050825
    [TBL] [Abstract][Full Text] [Related]  

  • 142. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
    Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
    J Exp Clin Cancer Res; 2021 Apr; 40(1):149. PubMed ID: 33931075
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells.
    Ramamoorthy P; Dandawate P; Jensen RA; Anant S
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33924995
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
    Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
    Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
    [TBL] [Abstract][Full Text] [Related]  

  • 145. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
    Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
    J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.
    Jalalirad M; Haddad TC; Salisbury JL; Radisky D; Zhang M; Schroeder M; Tuma A; Leof E; Carter JM; Degnim AC; Boughey JC; Sarkaria J; Yu J; Wang L; Liu MC; Zammataro L; Malatino L; Galanis E; Ingle JN; Goetz MP; D'Assoro AB
    Oncogene; 2021 Apr; 40(14):2509-2523. PubMed ID: 33674749
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Dll1
    Kumar S; Nandi A; Singh S; Regulapati R; Li N; Tobias JW; Siebel CW; Blanco MA; Klein-Szanto AJ; Lengner C; Welm AL; Kang Y; Chakrabarti R
    Nat Commun; 2021 Jan; 12(1):432. PubMed ID: 33462238
    [TBL] [Abstract][Full Text] [Related]  

  • 148. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
    Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
    [TBL] [Abstract][Full Text] [Related]  

  • 149. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
    Kim SL; Choi HS; Kim JH; Lee DS
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Advance in metabolism and target therapy in breast cancer stem cells.
    Gao X; Dong QZ
    World J Stem Cells; 2020 Nov; 12(11):1295-1306. PubMed ID: 33312399
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p.
    Mandal S; Gamit N; Varier L; Dharmarajan A; Warrier S
    Life Sci; 2021 Jan; 265():118854. PubMed ID: 33278391
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells.
    Darbankhales S; Mirfakhraie R; Ghahremani H; Asadolahi M; Saket-Kisomi K; Safakish L; Darbeheshti S; Ganjkhanlou Z; Salami S; Sirati-Sabet M
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3171-3176. PubMed ID: 33247672
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.
    Xu X; Zhang M; Xu F; Jiang S
    Mol Cancer; 2020 Nov; 19(1):165. PubMed ID: 33234169
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy.
    Guimei M; Alrouh S; Saber-Ayad M; Hafezi SA; Vinod A; Rawat S; Wardeh Y; Bakkour TM; El-Serafi AT
    Breast Cancer (Dove Med Press); 2020; 12():189-199. PubMed ID: 33173331
    [TBL] [Abstract][Full Text] [Related]  

  • 155. 6-Methoxymellein Isolated from Carrot (
    Liu R; Choi HS; Kim SL; Kim JH; Yun BS; Lee DS
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32977636
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Hippo Signaling in Embryogenesis and Development.
    Wu Z; Guan KL
    Trends Biochem Sci; 2021 Jan; 46(1):51-63. PubMed ID: 32928629
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Anthocyanins Isolated from
    Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
    [TBL] [Abstract][Full Text] [Related]  

  • 158. LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer.
    Kong Y; Ou X; Li X; Zeng Y; Gao G; Lyu N; Liu P
    Mol Ther Oncolytics; 2020 Sep; 18():351-359. PubMed ID: 32775619
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells.
    Galarza TE; Táquez Delgado MA; Mohamad NA; Martín GA; Cricco GP
    Biochem Pharmacol; 2020 Oct; 180():114177. PubMed ID: 32721509
    [TBL] [Abstract][Full Text] [Related]  

  • 160. 24-Dehydrocholesterol reductase promotes the growth of breast cancer stem-like cells through the Hedgehog pathway.
    Qiu T; Cao J; Chen W; Wang J; Wang Y; Zhao L; Liu M; He L; Wu G; Li H; Gu H
    Cancer Sci; 2020 Oct; 111(10):3653-3664. PubMed ID: 32713162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.